CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to GILD

Domvanalimab

Phase 3
Gilead Sciences, Inc. (GILD)

Phase 3

Development Phase

0

Upcoming Catalysts

1

Historical Events

0

Regulatory Approvals

Development History
Aug '26
GILDPhase 2
Completed

Domvanalimab Phase 2 Est. Readout

Domvanalimab
Aug 2026~
CT.gov
Competitive Landscape

0 competitors in Advanced Non-Small Cell Lung Cancer

View Full Landscape
Drug Information

Target Indication

Advanced Non-Small Cell Lung Cancer

Clinical Trial

NCT05676931

Last updated: 2/3/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.